This brings a basic research question: Could a more specific targeting of Hsp90 via modulation of PTMs or PTM-causing enzymes be a revolutionary therapeutic method for a variety of diseases where Hsp90 plays a role including cardiomyopathy? The gene discussed is HSP90AB1; the disease is cardiomyopathy.